Volume 26, Number 11—November 2020
Dispatch
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease
Ranawaka A.P.M. Perera, Eugene Tso, Owen T.Y. Tsang, Dominic N.C. Tsang, Kitty Fung, Yonna W.Y. Leung, Alex W.H. Chin, Daniel K.W. Chu, Samuel M.S. Cheng, Leo L.M. Poon, Vivien W.M. Chuang, and Malik Peiris
Table 2
Culture and sgRNA results stratified by specimen type for patients with mild coronavirus disease, Hong Kong*
| Specimen | Investigation | Days after onset of illness, no. positive/no. tested |
||||
|---|---|---|---|---|---|---|
| 1–2 | 3–8 | 9–14 | 15–21 | >21 | ||
| NPA + TS |
Culture | 8/14 | 2/14 | 0/8 | 0/2 | 0/8 |
| sgRNA |
8/11 |
4/4 |
0/1 |
0/0 |
0/4 |
|
| NPA |
Culture | 2/2 | ||||
| sgRNA |
1/1 |
|||||
| NPS + TS |
Culture | 0/2 | 0/2 | |||
| sgRNA |
||||||
| NPS |
Culture | 1/1 | 1/1 | 0/1 | ||
| sgRNA |
1/1 |
1/1 |
||||
| Sputum |
Culture | 0/1 | 0/2 | 0/8 | ||
| sgRNA |
1/1 |
1/1 |
0/5 |
|||
| Saliva | Culture | 2/2 | ||||
| sgRNA | 2/2 | |||||
*Blank cells indicate that no specimens were collected at that time point. NPA, nasopharyngeal aspirate; NPS, nasopharyngeal swab; sgRNA, subgenomic viral RNA: TS, throat swab.
Page created: July 28, 2020
Page updated: October 19, 2020
Page reviewed: October 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.